Newron Licenses Evenamide To EA Pharma For Asian Territories
13 Dec 2024 //
BUSINESSWIRE
Ensho emerges with inflammatory disease portfolio from Eisai`s EA Pharma
28 Jun 2024 //
FIERCE BIOTECH
Agreement for Oral ?4?7 Antagonist, between EA Pharma and Ensho Therapeutics
27 Jun 2024 //
GLOBENEWSWIRE